Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cerebrovasc Dis ; 44(1-2): 51-58, 2017.
Article in English | MEDLINE | ID: mdl-28427054

ABSTRACT

BACKGROUND: The beneficial effects of endovascular therapy (EVT) in acute ischemic stroke have been demonstrated in recent clinical trials using new-generation thrombectomy devices. However, the comparative effectiveness and safety of preceding intravenous thrombolysis (IVT) in this population has rarely been evaluated. METHODS: From a prospective multicenter stroke registry database in Korea, we identified patients with acute ischemic stroke who were treated with EVT within 8 h of onset and admitted to 14 participating centers during 2008-2013. The primary outcome was a modified Rankin Scale (mRS) score at 3 months. Major secondary outcomes were successful recanalization defined as a modified Treatment in Cerebral Ischemia score of 2b-3, functional independence (mRS score 0-2), mortality at 3 months, and symptomatic hemorrhagic transformation (SHT) during hospitalization. Multivariable logistic regression analyses using generalized linear mixed models were performed to estimate the adjusted odds ratios (ORs) of preceding IVT. RESULTS: Of the 639 patients (male, 61%; age 69 ± 12; National Institutes of Health Stroke Scale score of 15 [11-19]) who met the eligibility criteria, 458 received preceding IVT. These patients showed lower mRS scores (adjusted common OR, 1.38 [95% CI 0.98-1.96]). Preceding IVT was associated with successful recanalization (1.96 [1.23-3.11]) and reduced 3-month mortality (0.58 [0.35-0.97]) but not with SHT (0.96 [0.48-1.93]). CONCLUSION: In patients treated with EVT within 8 of acute ischemic stroke onset, preceding IVT may enhance survival and successful recanalization without additional risk of SHT, and mitigate disability at 3 months.


Subject(s)
Brain Ischemia/therapy , Endovascular Procedures , Fibrinolytic Agents/administration & dosage , Stroke/therapy , Thrombectomy , Thrombolytic Therapy/methods , Administration, Intravenous , Aged , Aged, 80 and over , Brain Ischemia/diagnosis , Brain Ischemia/mortality , Brain Ischemia/physiopathology , Comparative Effectiveness Research , Databases, Factual , Disability Evaluation , Endovascular Procedures/adverse effects , Endovascular Procedures/mortality , Female , Fibrinolytic Agents/adverse effects , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Recovery of Function , Registries , Republic of Korea , Retrospective Studies , Risk Factors , Stroke/diagnosis , Stroke/mortality , Stroke/physiopathology , Thrombectomy/adverse effects , Thrombectomy/mortality , Thrombolytic Therapy/adverse effects , Thrombolytic Therapy/mortality , Time Factors , Time-to-Treatment , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...